The alveolar epithelium is lined by surfactant, a lipoprotein complex that both reduces surface tension and mediates several innate immune functions including bacterial aggregation, alteration of alveolar macrophage function, and regulation of bacterial clearance.
Surfactant protein D (SP-D)1 is one of the four surfactant proteins that is synthesized by alveolar type II epithelial cells as a component of the lipoprotein complex known as pulmonary surfactant. Although SP-D has not been shown to participate in the surface tension-reducing properties of surfactant, it has been demonstrated to participate in the host defense functions of surfactant (1). SP-D as well as SP-A belong to the collectin family of proteins, named for their N-terminal collagen region and Cterminal lectin domain. Intact SP-D consists of four trimers, which interact in their N-terminal region to form a cruciform structure (2). The collectins are pattern recognition molecules that bind, in a calcium-dependent manner, to non-self oligosaccharides presented on the surface of many bacteria and viruses. (9).Pseudomonas aeruginosa is a Gram-negative bacterium that is the predominant cause of morbidity and mortality in patients with cystic fibrosis (CF) (10). P. aeruginosa infections are characterized by a mucoid biofilm consisting mainly of secreted oligosaccharides. The lipopolysaccharide expressed by mucoid P. aeruginosa is of the rough phenotype and is less cytotoxic than that of other Gram-negative bacteria (11). Virulence is induced by P. aeruginosa via secretion of several enzymes, the most cytotoxic of which is exotoxin A, which directly inhibits protein synthesis (12). In addition to this toxin, P. aeruginosa secretes several proteases including elastase (Las B), protease IV, Las A protease, and alkaline protease (13,14).Surfactant protein composition is altered in cystic fibrosis patients. Several reports have shown that whereas phospholipids levels are largely unchanged, the levels of both intact . Surfactant protein levels have also been shown to be altered in a rat model of P. aeruginosa infection, although SP-D levels were not measured (18). We have previously shown P. aeruginosa elastase degrades both SP-A and SP-D and that SP-A degradation fragments are present in the bronchoalveolar lavage (BAL) of cystic fibrosis patients after lung transplant (19). Detectable levels of P. aeruginosa elastase have been found in the BAL and serum of CF patients (20). Furthermore, histologic studies have detected abnormal elastin fibers in lung alveoli of CF patients on autopsy (21), and P. aeruginosa elastase activity was detectable in sputum samples. These data suggest that SP-D is probably cleaved by elastase in vivo during the progression of CF.We propose that P. aeruginosa elastase cleaves SP-D to a stable 35-kDa fragment, which has impaired immune regulatory function. To test this hypothesis, we purified both P. aeruginosa elastase by ion exchange chromatography and its 35-kDa SP-D cleavage product by gel filtration chromatogra-